Higher CSF neuroinflammatory biomarkers may be linked to AD pathology and cognitive impairment; however, given the observational design, causality cannot be established, and longitudinal mechanistic studies are needed to validate these findings.
Findings identify complement dysregulation, especially involving C1q, as an early correlate of tau-linked synaptic pathology, and support a role for complement activation in the AD molecular cascade.
J. Loncke, M. Savard, C. Picard et al.· bioRxiv· 0 citations
Background Alzheimer’s disease (AD) is one of the most prevalent neurodegenerative conditions. Chronic peripheral inflammation has been implicated in the pathophysiology of AD. Given their accessibility and cost-effectiveness, peripheral inflammatory biomarkers hold promise as potential indicators for AD. However, thei...
Yi-Da Wang, Min Cheng, Zun-Jing Liu· Frontiers in Neurology· 0 citations
Elevated NLR was significantly and independently associated with accelerated decline across multiple cognitive domains and an increased risk of clinical progression in older adults at risk for AD and a potential role for peripheral immune dysregulation in early disease trajectories is observed.
Xin Wang, Xiao-Lei Liu, Zhi-Gang Wang et al.· Frontiers in Aging Neuroscie...· 0 citations
It is shown that elevated plasma GFAP significantly modulates the association between p-tau217 and both cross-sectional cognitive severity and longitudinal clinical decline, and support that astrocyte reactivity is associated with greater cognitive impairment and faster clinical decline among individuals with elevated...
B. Bellaver, G. Povala, P. C. L. Ferreira et al.· Molecular Neurodegeneration· 0 citations
A BBB permeability-related score is associated with longitudinal progression from mild cognitive impairment to clinically diagnosed AD dementia; CD226 is a biologically supported candidate signal; GFRα-1 is hypothesis-generating pending replication.
Jing Yang· Neurological Sciences· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.